Wilcoxen KM - Search Results

1

Antibacterial agents based on the cyclic D,L-alpha-peptide architecture.

Fernandez-Lopez S, Kim HS, Choi EC, Delgado M, Granja JR, Khasanov A, Kraehenbuehl K, Long G, Weinberger DA, Wilcoxen KM, Ghadiri MR. Fernandez-Lopez S, et al. Among authors: wilcoxen km. Nature. 2001 Jul 26;412(6845):452-5. doi: 10.1038/35086601. Nature. 2001. PMID: 11473322

2

Automated mass spectrometric sequence determination of cyclic peptide library members.

Redman JE, Wilcoxen KM, Ghadiri MR. Redman JE, et al. Among authors: wilcoxen km. J Comb Chem. 2003 Jan-Feb;5(1):33-40. doi: 10.1021/cc0200639. J Comb Chem. 2003. PMID: 12523832

3

Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections.

Horne WS, Wiethoff CM, Cui C, Wilcoxen KM, Amorin M, Ghadiri MR, Nemerow GR. Horne WS, et al. Among authors: wilcoxen km. Bioorg Med Chem. 2005 Sep 1;13(17):5145-53. doi: 10.1016/j.bmc.2005.05.051. Bioorg Med Chem. 2005. PMID: 15993611 Free PMC article.

4

Functional and mechanistic analyses of biomimetic aminoacyl transfer reactions in de novo designed coiled coil peptides via rational active site engineering.

Leman LJ, Weinberger DA, Huang ZZ, Wilcoxen KM, Ghadiri MR. Leman LJ, et al. Among authors: wilcoxen km. J Am Chem Soc. 2007 Mar 14;129(10):2959-66. doi: 10.1021/ja068052x. Epub 2007 Feb 16. J Am Chem Soc. 2007. PMID: 17302417 Free PMC article.

5

Biomimetic catalysis of intermodular aminoacyl transfer.

Wilcoxen KM, Leman LJ, Weinberger DA, Huang ZZ, Ghadiri MR. Wilcoxen KM, et al. J Am Chem Soc. 2007 Jan 31;129(4):748-9. doi: 10.1021/ja067124h. J Am Chem Soc. 2007. PMID: 17243796 Free PMC article.

6

Design, synthesis and structure-activity relationships of novel imidazolo[1,2-a]pyrimid-5-ones as potent GnRH receptor antagonists.

Gross TD, Zhu YF, Saunders J, Wilcoxen KM, Gao Y, Connors PJ Jr, Guo Z, Struthers RS, Reinhart GJ, Chen C. Gross TD, et al. Among authors: wilcoxen km. Bioorg Med Chem Lett. 2002 Aug 19;12(16):2185-7. doi: 10.1016/s0960-894x(02)00371-2. Bioorg Med Chem Lett. 2002. PMID: 12127533

7

Optimization of 3-phenylpyrazolo[1,5-a]pyrimidines as potent corticotropin-releasing factor-1 antagonists with adequate lipophilicity and water solubility.

Chen C, Wilcoxen KM, Huang CQ, McCarthy JR, Chen T, Grigoriadis DE. Chen C, et al. Among authors: wilcoxen km. Bioorg Med Chem Lett. 2004 Jul 16;14(14):3669-73. doi: 10.1016/j.bmcl.2004.05.019. Bioorg Med Chem Lett. 2004. PMID: 15203140

8

Design and synthesis of 3-(2-pyridyl)pyrazolo[1,5-a]pyrimidines as potent CRF1 receptor antagonists.

Huang CQ, Wilcoxen KM, Grigoriadis DE, McCarthy JR, Chen C. Huang CQ, et al. Among authors: wilcoxen km. Bioorg Med Chem Lett. 2004 Aug 2;14(15):3943-7. doi: 10.1016/j.bmcl.2004.05.056. Bioorg Med Chem Lett. 2004. PMID: 15225703

9

Quinoline-carboxylic acids are potent inhibitors that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins.

Zhu YF, Wang XC, Connors P, Wilcoxen K, Gao Y, Gross R, Strack N, Gross T, McCarthy JR, Xie Q, Ling N, Chen C. Zhu YF, et al. Bioorg Med Chem Lett. 2003 Jun 2;13(11):1931-4. doi: 10.1016/s0960-894x(03)00322-6. Bioorg Med Chem Lett. 2003. PMID: 12749901

10

Synthesis of 3-phenylpyrazolo[4,3-b]pyridines via a convenient synthesis of 4-amino-3-arylpyrazoles and SAR of corticotropin-releasing factor receptor type-1 antagonists.

Wilcoxen K, Huang CQ, McCarthy JR, Grigoriadis DE, Chen C. Wilcoxen K, et al. Bioorg Med Chem Lett. 2003 Oct 6;13(19):3367-70. doi: 10.1016/s0960-894x(03)00621-8. Bioorg Med Chem Lett. 2003. PMID: 12951127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters